The Potential of Lipid Carriers With Sialidase mRNA Payloads as Broad-Spectrum Host-Directed Antivirals

Sialic acid is a monosaccharide found on the surface of cells in the respiratory tract and plays a crucial role in immune regulation and cell signaling. It is present in 2 main forms: α(2,3)-linked and α(2,6)-linked, throughout the human respiratory tract, where α(2,6)-linked sialic acids are more abundant in the upper respiratory tract, and α(2,3)-linked sialic acids are more abundant in the lower respiratory tract. These different forms of sialic acid serve as entry receptors for different World Health Organization Priority Pathogens, including members of the Orthomyxoviridae and Coronaviridae family. Hence, targeted cleavage of sialic acid could serve as a potential prophylactic and therapeutic antiviral strategy by reducing the presence of sialic acid on the host cell surface, thereby preventing virion binding and cell-to-cell transmission of the virus. Previous research has developed an inhaled sialidase capable of transiently cleaving sialic acid in the respiratory tract. However, the short duration of protection offered, adverse side effects, and generation of anti-sialidase antibodies by the host hindered the efficacy of the therapeutic. In contrast, a mRNA-encoded sialidase could remain on the surface of the cell for longer periods of time, conferring more sustained and comprehensive sialidase activity and protection against viral entry. To deliver the mRNA payload, liposomes and lipid nanoparticle-based delivery systems have demonstrated effective surface expression of mRNA transcripts through different administration methods, such as inhalation and injections. Taken all together, this shows a promising avenue of host-directed antiviral therapy, where delivering sialidase mRNA via liposomes or lipid nanoparticles could act as a broad-spectrum host-directed antiviral strategy. However, key questions remain regarding the optimal neuraminidase mRNA to express, the range of viruses this antiviral strategy could be effective against, the potential cytotoxicity of expressing enzymatic proteins on the surface of cells, and the effects of sustained sialic acid removal. Further investigation is needed to assess the feasibility and safety of this approach.

Authors

Institutions

Publication Details

Journal
Open Collections
Published
2026-10-15
DOI
https://doi.org/10.14288/ujemip.v9.203801
Primary Topic
RNA Interference and Gene Delivery
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The Potential of Lipid Carriers With Sialidase mRNA Payloads as Broad-Spectrum Host-Directed Antivirals

Chung Wah Cyrus Yong
Open Collections
RNA Interference and Gene Delivery
article

The Potential of Lipid Carriers With Sialidase mRNA Payloads as Broad-Spectrum Host-Directed Antivirals

Chung Wah Cyrus Yong
article en

Abstract

Sialic acid is a monosaccharide found on the surface of cells in the respiratory tract and plays a crucial role in immune regulation and cell signaling. It is present in 2 main forms: α(2,3)-linked and α(2,6)-linked, throughout the human respiratory tract, where α(2,6)-linked sialic acids are more abundant in the upper respiratory tract, and α(2,3)-linked sialic acids are more abundant in the lower respiratory tract. These different forms of sialic acid serve as entry receptors for different World Health Organization Priority Pathogens, including members of the Orthomyxoviridae and Coronaviridae family. Hence, targeted cleavage of sialic acid could serve as a potential prophylactic and therapeutic antiviral strategy by reducing the presence of sialic acid on the host cell surface, thereby preventing virion binding and cell-to-cell transmission of the virus. Previous research has developed an inhaled sialidase capable of transiently cleaving sialic acid in the respiratory tract. However, the short duration of protection offered, adverse side effects, and generation of anti-sialidase antibodies by the host hindered the efficacy of the therapeutic. In contrast, a mRNA-encoded sialidase could remain on the surface of the cell for longer periods of time, conferring more sustained and comprehensive sialidase activity and protection against viral entry. To deliver the mRNA payload, liposomes and lipid nanoparticle-based delivery systems have demonstrated effective surface expression of mRNA transcripts through different administration methods, such as inhalation and injections. Taken all together, this shows a promising avenue of host-directed antiviral therapy, where delivering sialidase mRNA via liposomes or lipid nanoparticles could act as a broad-spectrum host-directed antiviral strategy. However, key questions remain regarding the optimal neuraminidase mRNA to express, the range of viruses this antiviral strategy could be effective against, the potential cytotoxicity of expressing enzymatic proteins on the surface of cells, and the effects of sustained sialic acid removal. Further investigation is needed to assess the feasibility and safety of this approach.

Open Collections
University of British Columbia (CA)
Good health and well-being
Openalex Percentile: Top 24%
RNA Interference and Gene Delivery
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.